Marpai (Marpai) ROCE % : -150.52% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Marpai ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Marpai's annualized ROCE % for the quarter that ended in Dec. 2023 was -150.52%.

Marpai ROCE % Historical Data

The historical data trend for Marpai's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marpai ROCE % Chart

Marpai Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-84.48

-85.05

-81.41

-126.72

Marpai Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial										-142.58	-118.39	-124.91	-150.86	-150.52

Marpai ROCE % Calculation

Marpai's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-27.515	/	( ( (49.95 - 17.36)	+	(31.679 - 20.843) )	/ 2 )
	=	-27.515	/	( (32.59	+	10.836)	/ 2 )
	=	-27.515	/	21.713
	=	-126.72 %

Marpai's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-19.568	/	( ( (35.611 - 20.447)	+	(31.679 - 20.843) )	/ 2 )
	=	-19.568	/	( ( 15.164	+	10.836 )	/ 2 )
	=	-19.568	/	13
	=	-150.52 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Marpai (NAS:MRAI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Marpai ROCE % Related Terms

Thank you for viewing the detailed overview of Marpai's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Marpai (Marpai) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Marpai Inc (NAS:MRAI) » Definitions » ROCE %

Comparable Companies

PFHO UNH ELV CI CVS HUM CNC MOH SZSE:000503 ALHC BSP:ODPV3 OSCR CLOV BSP:QUAL3 BHG ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

N/A

Address

5701 East Hillsborough Avenue, Suite 1417, Tampa, FL, USA, 33610-5428

Website

https://www.marpaihealth.com

Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients' health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.

Executives

Yaron Eitan	director	65 CHALLENGER ROAD, RIDGEFIELD PARK NJ 07660
Damien Lamendola	director, 10 percent owner	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Edmundo Gonzalez	director, officer: CEO, Secretary and Director	C/O SELWAY CAPITAL ACQUISITION CORP., 74 GRAND AVENUE, 2ND FLOOR, ENGLEWOOD NJ 07631
Sagiv Shiv	director
Vincent Kane	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131
Ronnie Brown	officer: Chief Operating Officer	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Mohsen Moazami	director	C/O ASTREA ACQUISITION CORP., 55 OCEAN LANE DRIVE, APT. 3021, KEY BISCAYNE FL 33149
Lutz Finger	officer: See Remarks	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610
Yoram Bibring	officer: Chief Financial Officer	C/O SELWAY ACQUISITION CORPORATION, 66 FORD ROAD, SUITE 230, DENVILLE NJ 07834
Jane Cavalier	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Diclaudio Colleen	director	456 SEATON STREET, LOS ANGELES CA 90013
Art Hoath	officer: Chief Revenue Officer	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Gonen Antebi	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Eli David	other: See footnote (1)	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131